These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 36761724)

  • 61. Prophylactic dendritic cell vaccination controls pancreatic cancer growth in a mouse model.
    Shangguan A; Shang N; Figini M; Pan L; Yang J; Ma Q; Hu S; Eresen A; Sun C; Wang B; Velichko Y; Yaghmai V; Zhang Z
    Cytotherapy; 2020 Jan; 22(1):6-15. PubMed ID: 32005355
    [TBL] [Abstract][Full Text] [Related]  

  • 62. DNA is an efficient booster of dendritic cell-based vaccine.
    Li J; Valentin A; Beach RK; Alicea C; Felber BK; Pavlakis GN
    Hum Vaccin Immunother; 2015; 11(8):1927-35. PubMed ID: 26125100
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer.
    Awad MM; Govindan R; Balogh KN; Spigel DR; Garon EB; Bushway ME; Poran A; Sheen JH; Kohler V; Esaulova E; Srouji J; Ramesh S; Vyasamneni R; Karki B; Sciuto TE; Sethi H; Dong JZ; Moles MA; Manson K; Rooney MS; Khondker ZS; DeMario M; Gaynor RB; Srinivasan L
    Cancer Cell; 2022 Sep; 40(9):1010-1026.e11. PubMed ID: 36027916
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunity.
    Liu L; Chen J; Zhang H; Ye J; Moore C; Lu C; Fang Y; Fu YX; Li B
    Nat Cancer; 2022 Apr; 3(4):437-452. PubMed ID: 35393580
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Optimizing dendritic cell vaccine for immunotherapy in multiple myeloma: tumour lysates are more potent tumour antigens than idiotype protein to promote anti-tumour immunity.
    Hong S; Li H; Qian J; Yang J; Lu Y; Yi Q
    Clin Exp Immunol; 2012 Nov; 170(2):167-77. PubMed ID: 23039887
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Enhanced detection of neoantigen-reactive T cells targeting unique and shared oncogenes for personalized cancer immunotherapy.
    Yossef R; Tran E; Deniger DC; Gros A; Pasetto A; Parkhurst MR; Gartner JJ; Prickett TD; Cafri G; Robbins PF; Rosenberg SA
    JCI Insight; 2018 Oct; 3(19):. PubMed ID: 30282837
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Development of cell-based tuberculosis vaccines: genetically modified dendritic cell vaccine is a much more potent activator of CD4 and CD8 T cells than peptide- or protein-loaded counterparts.
    Malowany JI; McCormick S; Santosuosso M; Zhang X; Aoki N; Ngai P; Wang J; Leitch J; Bramson J; Wan Y; Xing Z
    Mol Ther; 2006 Apr; 13(4):766-75. PubMed ID: 16343993
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Generation of Tumor-Specific Cytotoxic T Cells From Blood
    Kiessling A; Ramanathan K; Nilsson OB; Notari L; Renken S; Kiessling R; Grönlund H; Wickström SL
    Front Oncol; 2022; 12():866763. PubMed ID: 35433456
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Durable complete response to neoantigen-loaded dendritic-cell vaccine following anti-PD-1 therapy in metastatic gastric cancer.
    Guo Z; Yuan Y; Chen C; Lin J; Ma Q; Liu G; Gao Y; Huang Y; Chen L; Chen LZ; Huang YF; Wang H; Li B; Chen Y; Zhang X
    NPJ Precis Oncol; 2022 Jun; 6(1):34. PubMed ID: 35661819
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Engineered exosomes as an in situ DC-primed vaccine to boost antitumor immunity in breast cancer.
    Huang L; Rong Y; Tang X; Yi K; Qi P; Hou J; Liu W; He Y; Gao X; Yuan C; Wang F
    Mol Cancer; 2022 Feb; 21(1):45. PubMed ID: 35148751
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Biomaterials-assisted construction of neoantigen vaccines for personalized cancer immunotherapy.
    Wu Y; Feng L
    Expert Opin Drug Deliv; 2023 Mar; 20(3):323-333. PubMed ID: 36634017
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Diverse Neoantigens and the Development of Cancer Therapies.
    Srivastava RM; Purohit TA; Chan TA
    Semin Radiat Oncol; 2020 Apr; 30(2):113-128. PubMed ID: 32381291
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dendritic cells in pancreatic cancer immunotherapy: Vaccines and combination immunotherapies.
    Yang J; Shangguan J; Eresen A; Li Y; Wang J; Zhang Z
    Pathol Res Pract; 2019 Dec; 215(12):152691. PubMed ID: 31676092
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A Potent Micron Neoantigen Tumor Vaccine GP-Neoantigen Induces Robust Antitumor Activity in Multiple Tumor Models.
    Jing Z; Wang S; Xu K; Tang Q; Li W; Zheng W; Shi H; Su K; Liu Y; Hong Z
    Adv Sci (Weinh); 2022 Aug; 9(24):e2201496. PubMed ID: 35712770
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Dendritic cell vaccination with a toll-like receptor agonist derived from mycobacteria enhances anti-tumor immunity.
    Vo MC; Lee HJ; Kim JS; Hoang MD; Choi NR; Rhee JH; Lakshmanan VK; Shin SJ; Lee JJ
    Oncotarget; 2015 Oct; 6(32):33781-90. PubMed ID: 26418952
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Leveraging a powerful allogeneic dendritic cell line towards neoantigen-based cancer vaccines.
    Hannani D; Leplus E; Laulagnier K; Chaperot L; Plumas J
    Genes Cancer; 2023; 14():3-11. PubMed ID: 36726965
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Application prospect of circular RNA-based neoantigen vaccine in tumor immunotherapy.
    Li M; Wang Y; Wu P; Zhang S; Gong Z; Liao Q; Guo C; Wang F; Li Y; Zeng Z; Yan Q; Xiong W
    Cancer Lett; 2023 Jun; 563():216190. PubMed ID: 37062328
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy.
    Hradilova N; Sadilkova L; Palata O; Mysikova D; Mrazkova H; Lischke R; Spisek R; Adkins I
    PLoS One; 2017; 12(2):e0171539. PubMed ID: 28187172
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Enhancement of dendritic cell immunotherapy by recalling antigens for hepatocellular carcinoma in mice.
    Lee WC; Cheng CH; Lee CF; Hsu HY; Hsu PY; Wu TJ; Chan KM
    Immunotherapy; 2022 Oct; 14(15):1225-1236. PubMed ID: 36097695
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.